Be it wellness supplements to critical onco-nutritional formulations, market trends and business strategies, regulatory updates, leadership insights, and showcasing technology and innovation, Express Nutra aims to be the voice of this dynamic industry
‘Let food be thy medicine and medicine be thy food’, is a quote frequently attributed to Hippocrates, the father of modern medicine. Centuries later, nutraceuticals, a word coined by joining “nutrition” and “pharmaceutical”, best reflects this Hippocratic message.
Nutraceuticals took centre stage during the COVID lockdowns, when the world turned to preventive health, to ward off the virus. The transition from health-seeking to wellness-seeking is here to stay, reflected in the increased sales of ‘wellness’ products like immunity-enhancing formulations. With a plethora of product launches and more companies joining the fray, industry estimates predict that India’s nutra market will grow from $4 billion in 2020 to $18 billion by 2025, with a CAGR of 13.6 per cent expected from 2025 to 2030.
Having covered the evolution of the pharma sector since December 1994, Express Pharma launches Express Nutra in February 2025, to provide a neutral platform to all stakeholders, regulators and policymakers, established pharma and FMCG companies diversifying with a nutra play, pure play nutra organisations and startups either re-packaging ancient nutrients into contemporary avatars or launching desi versions of global trendsetters.
Partnering with multiple stakeholders, Express Nutra will surf the sangam of science, shifting demographics, consumer-driven health trends, and a lot more. Starting off as we mean to go on, in our inaugural edition, our lead story attempts to crack the regulatory code for nutra.
In India, we have the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022. The regulation covers five categories of food : Health Supplements, Nutraceuticals, Food for Special Dietary Use (FSDU) and Foods for Special Medical Purpose (FSMP), Prebiotic Food and Probiotics Food.
With medicine watchdog CDSCO stepping into the fray and tightening scrutiny, the industry is divided on the pros and cons. Our story, ‘Balancing safety and business in India’s nutra market’, has all the details. Will increasing regulatory scrutiny cool the jets of investors funding startups and M&As in the nutra sector? Not likely, says Subhakanta Bal, MD, Rothschild & Co. Read his interview explaining why the nutra sector expects to see continued investments and acquisitions.
Also, get a glimpse of how nutra players are taking lessons from pharma’s supply chain COVID meltdown to ensure their vendor and ingredient sourcing networks, etc are more resilient and shock-resistant.
Express Nutra is set to be launched at two of India’s biggest nutra-focused conferences, Vitafoods India 2025 (Feb 5-7, 2025) and the annual conference of the Health Food and Dietary Supplements Association (HADSA) (March 21, 2025). Both conferences will turbocharge India’s nutra sector, with a focus on science-based strategies to meet India’s and the world’s unmet nutra needs.
Be it wellness supplements and critical onco-nutritional formulations, market trends and business strategies, regulatory updates, leadership insights, and showcasing technology and innovation, Express Nutra aims to be the voice of this dynamic industry. We look forward to feedback and suggestions on how we can become the go-to resource for nutra business leaders, bridging gaps, connecting stakeholders and fostering collaboration for sustainable growth.
